Business Description
3B BlackBio Dx Ltd
ISIN : INE994E01018
Total Employee Number:
85Compare
Compare
Traded in other countries / regions
532067.India IPO Date
1996-10-23Description
3B BlackBio Dx Ltd is an Indian company specializing in PCR-based Molecular Diagnostic Kits. The company is involved in designing, developing, manufacturing, and commercializing PCR-based Molecular Diagnostic kits, PCR Enzymes, and PCR Reagents.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 32.46 | |||||
Equity-to-Asset | 0.86 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | 0.04 | |||||
Interest Coverage | 216.27 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 15.75 | |||||
Beneish M-Score | -2.2 | |||||
WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 32.9 | |||||
3-Year EBITDA Growth Rate | 32.3 | |||||
3-Year EPS without NRI Growth Rate | 35.9 | |||||
3-Year FCF Growth Rate | 14.7 | |||||
3-Year Book Growth Rate | 13.7 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 36.32 | |||||
9-Day RSI | 48.67 | |||||
14-Day RSI | 51.55 | |||||
3-1 Month Momentum % | -3.15 | |||||
6-1 Month Momentum % | -29.92 | |||||
12-1 Month Momentum % | -24 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 5.27 | |||||
Quick Ratio | 4.77 | |||||
Cash Ratio | 2.76 | |||||
Days Inventory | 168.08 | |||||
Days Sales Outstanding | 117.52 | |||||
Days Payable | 47.19 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 0.32 | |||||
Dividend Payout Ratio | 0.06 | |||||
3-Year Dividend Growth Rate | 17 | |||||
Forward Dividend Yield % | 0.32 | |||||
5-Year Yield-on-Cost % | 0.32 | |||||
3-Year Average Share Buyback Ratio | -4.6 | |||||
Shareholder Yield % | 0.21 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 74.47 | |||||
Operating Margin % | 36.13 | |||||
Net Margin % | 41.28 | |||||
EBITDA Margin % | 58.01 | |||||
FCF Margin % | 19 | |||||
OCF Margin % | 36.98 | |||||
ROE % | 19.73 | |||||
ROA % | 17.32 | |||||
ROIC % | 15.8 | |||||
3-Year ROIIC % | 16.13 | |||||
ROC (Joel Greenblatt) % | 106.33 | |||||
ROCE % | 24.82 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 18.42 | |||||
PE Ratio without NRI | 18.42 | |||||
Shiller PE Ratio | 25.82 | |||||
Price-to-Owner-Earnings | 22.09 | |||||
PS Ratio | 7.6 | |||||
PB Ratio | 3.36 | |||||
Price-to-Tangible-Book | 3.3 | |||||
Price-to-Free-Cash-Flow | 39.47 | |||||
Price-to-Operating-Cash-Flow | 20.29 | |||||
EV-to-EBIT | 12.72 | |||||
EV-to-EBITDA | 11.92 | |||||
EV-to-Revenue | 6.92 | |||||
EV-to-FCF | 37.35 | |||||
Price-to-GF-Value | 0.58 | |||||
Price-to-Projected-FCF | 1.4 | |||||
Price-to-Median-PS-Value | 2.18 | |||||
Price-to-Graham-Number | 1.63 | |||||
| Price-to-Net-Current-Asset-Value | 7.71 | |||||
| Price-to-Net-Cash | 22.71 | |||||
Earnings Yield (Greenblatt) % | 7.87 | |||||
FCF Yield % | 2.52 | |||||
Forward Rate of Return (Yacktman) % | -3.24 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
3B BlackBio Dx Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 1,419.181 | ||
| EPS (TTM) (₹) | 68.976 | ||
| Beta | 0.6179 | ||
| 3-Year Sharpe Ratio | 0.84 | ||
| 3-Year Sortino Ratio | 1.65 | ||
| Volatility % | 37.73 | ||
| 14-Day RSI | 51.55 | ||
| 14-Day ATR (₹) | 46.634309 | ||
| 20-Day SMA (₹) | 1239.72 | ||
| 12-1 Month Momentum % | -24 | ||
| 52-Week Range (₹) | 1083.5 - 1750 | ||
| Shares Outstanding (Mil) | 8.58 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
3B BlackBio Dx Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
3B BlackBio Dx Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| INR 4.000000 Cash Dividend | 2025-09-19 | 1,398.70 (-0.73%) | ||
| INR 3.000000 Cash Dividend | 2024-09-17 | 1,410.05 (-3.41%) |
Show
Entries
3B BlackBio Dx Ltd Frequently Asked Questions
What is 3B BlackBio Dx Ltd(BOM:532067)'s stock price today?
The current price of BOM:532067 is ₹1248.90. The 52 week high of BOM:532067 is ₹1750.00 and 52 week low is ₹1083.50.
When is next earnings date of 3B BlackBio Dx Ltd(BOM:532067)?
The next earnings date of 3B BlackBio Dx Ltd(BOM:532067) is .
Does 3B BlackBio Dx Ltd(BOM:532067) pay dividends? If so, how much?
The Dividend Yield %  of 3B BlackBio Dx Ltd(BOM:532067) is 0.32% (As of Today), Highest Dividend Payout Ratio of 3B BlackBio Dx Ltd(BOM:532067) was 0.12. The lowest was 0.02. And the median was 0.06. The  Forward Dividend Yield % of 3B BlackBio Dx Ltd(BOM:532067) is 0.32%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on 3B BlackBio Dx Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers